AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31888723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 31888723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Metoprolol and Placebo)
Number of subjects: 130
Study 28390325 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord clamped at <15 seconds
Number of subjects: 156
Study 28390325 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord clamped between 60 ‐ 75 seconds
Number of subjects: 156
Study 28390325 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord clamped between 120 ‐ 135 seconds
Number of subjects: 156
Study 28390325 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 156
Study 28390325 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping
Number of subjects: 156
Study 26378681 — intervention group
Group type: EXPERIMENTAL
Intervention: Salsalate (2500-4500 mg for 4 days)
Number of subjects: 31
Study 26378681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 23694720 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2140023 (40 mg BID)
Number of subjects: 261
Study 23694720 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC: olanzapine, risperidone, or aripiprazole)
Number of subjects: 261
Study 21381872 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) without thrombin activation
Number of subjects: 2
Study 21381872 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) combined with bovine anorganic bone mineral (ABM)
Number of subjects: 2
Study 21381872 — intervention group
Group type: COMPARATOR
Intervention: Control group (PRP without ABM)
Number of subjects: 2
Study 19240199 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrastriate VRT
Number of subjects: 18
Study 19240199 — intervention group
Group type: COMPARATOR
Intervention: Standard VRT
Number of subjects: 18
Study 19240199 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI-VFQ
Number of subjects: 18
Study 17202009 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 71
Study 17202009 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 71
Study 15595336 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring System (CGMS)
Number of subjects: 128
Study 15595336 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 128
Study 15595336 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CGMS and SMBG
Number of subjects: 128
Study 11915779 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB (40mg/kg bodyweight/day)
Number of subjects: 17
Study 11915779 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 17
Study 9415330 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin, polymyxin E, and amphotericin
Number of subjects: 0
Study 9415330 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (diphenhydramine, Maalox, and local analgesic)
Number of subjects: 0
Study 7857700 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen
Number of subjects: 623
Study 7857700 — intervention group
Group type: COMPARATOR
Intervention: Not treated with adjuvant tamoxifen
Number of subjects: 623
Study 3680604 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 0
Study 3680604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0
Study 3680604 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 3680604 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 3680604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31944546 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher starting dose of insulin glargine 100 U/mL (0.3 U/kg)
Number of subjects: 866
Study 31944546 — intervention group
Group type: COMPARATOR
Intervention: Standard starting dose of insulin glargine 100 U/mL (0.2 U/kg)
Number of subjects: 866
Study 30084822 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin-collagen combined with autologous platelet-rich plasma (PRP)
Number of subjects: 39
Study 30084822 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 39
Study 26537735 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation, 6 g daily (3.9 g n-3 PUFA) for 9 months
Number of subjects: 36
Study 26537735 — intervention group
Group type: COMPARATOR
Intervention: Maize oil (MO) supplementation, 6 g daily for 9 months
Number of subjects: 36
Study 23826645 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-flap (OF) esthetic crown lengthening
Number of subjects: 28
Study 23826645 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless (FL) esthetic crown lengthening
Number of subjects: 28
Study 24295143 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional and behavioral management strategies used by lower grade teachers
Number of subjects: 317
Study 24295143 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional and behavioral management strategies used by upper grade teachers
Number of subjects: 317
Study 24295143 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrepancy scores of instructional and behavioral management strategies for upper grade teachers
Number of subjects: 317
Study 24295143 — intervention group
Group type: COMPARATOR
Intervention: Years of teaching experience
Number of subjects: 317
Study 24295143 — intervention group
Group type: COMPARATOR
Intervention: Years of teaching experience and grade-level assignment interaction
Number of subjects: 317
Study 19897551 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacity of Daily Living during the Morning (CDLM) questionnaire
Number of subjects: 1100
Study 19897551 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Chest Symptoms Questionnaire (GCSQ)
Number of subjects: 1100
Study 19897551 — intervention group
Group type: EXPERIMENTAL
Intervention: CDLM and GCSQ scores
Number of subjects: 1100
Study 18947140 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic interventions in CRTs
Number of subjects: 0
Study 18947140 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen
Number of subjects: 6105
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 6105
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma viscosity, tPA, and d-dimer
Number of subjects: 6105
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA
Number of subjects: 6105
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen and CRP
Number of subjects: 6105
Study 16151030 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen, CRP, plasma viscosity, tPA, d-dimer
Number of subjects: 6105
Study 12814145 — intervention group
Group type: EXPERIMENTAL
Intervention: Coriolus versicolor polysaccharide peptide (PSP)
Number of subjects: 34
Study 12814145 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 12640352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide
Number of subjects: 42
Study 12640352 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 42
Study 12640352 — intervention group
Group type: COMPARATOR
Intervention: Rate Control
Number of subjects: 42
Study 12640352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide and Propafenone
Number of subjects: 42
Study 10466566 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (informed of validation procedure)
Number of subjects: 0
Study 10466566 — intervention group
Group type: COMPARATOR
Intervention: Control group (not informed of validation procedure)
Number of subjects: 0
Study 7783313 — intervention group
Group type: EXPERIMENTAL
Intervention: TAZ/PIPC (2.5 g twice a day for 14 days)
Number of subjects: 164
Study 7783313 — intervention group
Group type: COMPARATOR
Intervention: PIPC (2.0 g twice a day for 14 days)
Number of subjects: 164
Study 7783313 — intervention group
Group type: EXPERIMENTAL
Intervention: TAZ/PIPC
Number of subjects: 164
Study 7783313 — intervention group
Group type: COMPARATOR
Intervention: PIPC
Number of subjects: 164
Study 2128828 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with leuprolide and flutamide
Number of subjects: 603
Study 2128828 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide alone
Number of subjects: 603
Study 319662 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (5 to 10 mg)
Number of subjects: 16
Study 319662 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (10 to 30 mg)
Number of subjects: 16
Study 319662 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (7.5 to 20 mg)
Number of subjects: 16
Study 319662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31250758 — intervention group
Group type: EXPERIMENTAL
Intervention: M2000 (mannuronic acid) 500mg orally twice per day for 12 weeks
Number of subjects: 15
Study 31250758 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 healthy participants)
Number of subjects: 15
Study 28237542 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant retained overdentures
Number of subjects: 56
Study 28237542 — intervention group
Group type: COMPARATOR
Intervention: Two-implant retained overdentures
Number of subjects: 56
Study 26014298 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus RT/TMZ
Number of subjects: 0
Study 26014298 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus RT/TMZ
Number of subjects: 0
Study 23176599 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management dietary counselling (SMDC) in Group A (n = 41)
Number of subjects: 122
Study 23176599 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational games in Group B (n = 41)
Number of subjects: 122
Study 23176599 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C) (n = 40)
Number of subjects: 122
Study 20495936 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment during gestation
Number of subjects: 246
Study 18844508 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIP intervention
Number of subjects: 348
Study 16428535 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugarless bubble gum
Number of subjects: 3
Study 16428535 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugared bubble gum
Number of subjects: 3
Study 16428535 — intervention group
Group type: COMPARATOR
Intervention: No gum (Control)
Number of subjects: 3
Study 15645905 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice containing calcium, phosphate, and sodium bicarbonate
Number of subjects: 113
Study 15645905 — intervention group
Group type: COMPARATOR
Intervention: Commercially available fluoride and silica-containing dentifrice
Number of subjects: 113
Study 11783068 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical lymphadenectomy (RL)
Number of subjects: 320
Study 11783068 — intervention group
Group type: COMPARATOR
Intervention: Conventional lymph node dissection (control)
Number of subjects: 320
Study 9373050 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5-5 mg, slow-release)
Number of subjects: 26
Study 9373050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 8207317 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH-Fluxum 3200 IUaXa daily (Group A)
Number of subjects: 39
Study 8207317 — intervention group
Group type: COMPARATOR
Intervention: Calcium heparin 5000 IU three times daily (Group B)
Number of subjects: 39
Study 29574421 — intervention group
Group type: EXPERIMENTAL
Intervention: EmboTrap device
Number of subjects: 201
Study 26728864 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of canned food
Number of subjects: 184
Study 26728864 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of alcoholic drinks at least weekly
Number of subjects: 184
Study 26728864 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 184
Study 26728864 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of fast food
Number of subjects: 184
Study 25014621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-speed resistance training (EG)
Number of subjects: 45
Study 25014621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-speed resistance training (SG)
Number of subjects: 45
Study 25014621 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study 22670252 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) and porous hydroxyapatite
Number of subjects: 60
Study 22670252 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyapatite and saline
Number of subjects: 60
Study 20027119 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-source CT (DSCT)
Number of subjects: 29
Study 20027119 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 29
Study 18433425 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine 16.2 mg p.o. t.i.d. for 7 days
Number of subjects: 30
Study 18433425 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 18433425 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 30
Study 16154274 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine (4-6mg dosed by ideal body weight)
Number of subjects: 60
Study 16154274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16154274 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine minus placebo analgesia calculation
Number of subjects: 60
Study 14989112 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of inhaled corticosteroid (ICS) therapy
Number of subjects: 19
Study 14989112 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroid (ICS) therapy continued
Number of subjects: 19
Study 14989112 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of ICS therapy
Number of subjects: 19
Study 10634835 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient triggered ventilation
Number of subjects: 386
Study 10634835 — intervention group
Group type: COMPARATOR
Intervention: Conventional fast rate ventilation
Number of subjects: 386
Study 8894800 — intervention group
Group type: EXPERIMENTAL
Intervention: Marvelon
Number of subjects: 66
Study 8894800 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane
Number of subjects: 66
Study 1517921 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (2000 IU retinyl palmitate, n = 27)
Number of subjects: 49
Study 1517921 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (n = 22)
Number of subjects: 49
Study 1517921 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (2000 IU retinyl palmitate)
Number of subjects: 49
Study 1517921 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 49
Study 6383927 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotard MC + Actrapid MC (human insulin)
Number of subjects: 135
Study 6383927 — intervention group
Group type: COMPARATOR
Intervention: Monotard HM + Actrapid HM (porcine insulin)
Number of subjects: 135
Study 31345007 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute Pro® (ABS)
Number of subjects: 197
Study 31345007 — intervention group
Group type: COMPARATOR
Intervention: Complete SE® (COM)
Number of subjects: 197
Study 30052317 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of a representative antiperspirant formulation containing 26 Al chlorohydrate (ACH)
Number of subjects: 12
Study 26982078 — intervention group
Group type: EXPERIMENTAL
Intervention: Quincke needle
Number of subjects: 126
Study 26982078 — intervention group
Group type: COMPARATOR
Intervention: Whitacre needle
Number of subjects: 126
Study 26982078 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive aspiration test
Number of subjects: 126
Study 24642190 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with a volar locking plate
Number of subjects: 90
Study 24642190 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction followed by plaster immobilisation
Number of subjects: 90
Study 22941746 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for UHR patients plus treatment as usual (CBTuhr)
Number of subjects: 201
Study 22941746 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 201
Study 19838862 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocus sativus (saffron) 30 mg/day (15 mg twice per day)
Number of subjects: 54
Study 19838862 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 10 mg/day (5 mg twice per day)
Number of subjects: 54
Study 18023680 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting with intensive medical therapy
Number of subjects: 1000
Study 18023680 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ventricular reconstruction plus coronary artery bypass grafting
Number of subjects: 1000
Study 18023680 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1000
Study 18023680 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy and coronary artery bypass grafting
Number of subjects: 1000
Study 18023680 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy and coronary artery bypass grafting with surgical ventricular reconstruction
Number of subjects: 1000
Study 16244269 — intervention group
Group type: EXPERIMENTAL
Intervention: Early information arm with MR results provided within 48 hours
Number of subjects: 246
Study 16244269 — intervention group
Group type: COMPARATOR
Intervention: Control arm where patients and physicians were blinded to MR results
Number of subjects: 246
Study 12045679 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI-containing triple therapy
Number of subjects: 43
Study 12045679 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-drug regimen
Number of subjects: 43
Study 12045679 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-containing triple therapy
Number of subjects: 43
Study 12045679 — intervention group
Group type: COMPARATOR
Intervention: Double NRTI therapy
Number of subjects: 43
Study 9528731 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily for 12 weeks
Number of subjects: 108
Study 9528731 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release niacin 1 g three times daily for 12 weeks
Number of subjects: 108
Study 8558884 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired comparisons method
Number of subjects: 80
Study 8558884 — intervention group
Group type: EXPERIMENTAL
Intervention: Category rating method
Number of subjects: 80
Study 2104939 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (Indo) 100 mg IV 6 hours postoperatively and 3 x 50 mg IV Indo over 24 hours on postoperative days 1, 2, 3, 4
Number of subjects: 43
Study 2104939 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (Indo)
Number of subjects: 43
Study 2104939 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 43
Study 853204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclandelate
Number of subjects: 39
Study 30702021 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding nitinol stents
Number of subjects: 105
Study 30702021 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 105
Study 29386335 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 52
Study 29386335 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 52
Study 27591917 — intervention group
Group type: EXPERIMENTAL
Intervention: Defined symptom-change trajectories (linear, log-linear, one-step) during acute-phase cognitive therapy
Number of subjects: 220
Study 24973196 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized educational intervention (40-min one-to-one session using motivational interviewing techniques, reinforced at 1 and 6 months)
Number of subjects: 1947
Study 24973196 — intervention group
Group type: COMPARATOR
Intervention: Usual in-hospital education (control group)
Number of subjects: 1947
Study 21691843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2677
Study 20594395 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g farmed trout raised on marine feed
Number of subjects: 68
Study 20594395 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g farmed trout raised on vegetable feed
Number of subjects: 68
Study 20594395 — intervention group
Group type: COMPARATOR
Intervention: 150 g chicken
Number of subjects: 68
Study 17321529 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mug of oral misoprostol
Number of subjects: 622
Study 17321529 — intervention group
Group type: COMPARATOR
Intervention: 5 U of intravenous oxytocin
Number of subjects: 622
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreoretinal surgery (scleral buckling and/or vitrectomy)
Number of subjects: 401
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral buckle only
Number of subjects: 401
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation (no surgery)
Number of subjects: 401
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreoretinal surgery for stage 4A retinal detachment
Number of subjects: 401
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreoretinal surgery for stage 5 disease
Number of subjects: 401
Study 16401781 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes of retinal detachment due to ROP
Number of subjects: 401
Study 12418945 — intervention group
Group type: COMPARATOR
Intervention: Clinic heart rate greater than 79 bpm
Number of subjects: 4682
Study 12418945 — intervention group
Group type: COMPARATOR
Intervention: Clinic heart rate
Number of subjects: 4682
Study 12418945 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory heart rate
Number of subjects: 4682
Study 10352633 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlicensed homes
Number of subjects: 301